mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
9e-15 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-14 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
9e-12 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-11 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.38 |
8e-10 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.29 |
1e-09 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-09 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-09 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-08 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-08 |